Public Health Forum, Dec 12: ‘Translational Genomics and Health Outcomes’.
“Translational Genomics and Health Outcomes: A New Research Discipline”
Wednesday, Dec. 12 from noon-1 p.m.
Medical Instructional Building, Room L110
Robert C. Green, MD, MPH
Director, G2P Research Program
Associate Director for Research, Partners Center for Personalized Genetic Medicine
Division of Genetics, Department of Medicine
Brigham and Women’s Hospital and Harvard Medical School
Robert C. GreenRobert C. Green, MD, MPH is Lecturer on Medicine in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School and Associate Director for Research at the Partners HealthCare Center for Personalized Genetic Medicine. His research interests have evolved from a focus on clinical trials and genetic epidemiology to a focus on translational genomics and health outcomes.
He has been continuously funded by NIH for 21 years and has published over 300 articles. Key contributions have included the development of risk estimates based on family history and genetic markers, leadership and analysis of large multi-center treatment and prevention trials, including trials enriched through family history, and design, leadership and future planning of the first large-scale randomized clinical trials in translational genetics.
He serves on a number of advisory, editorial and grant review boards and is a regular member of the National Human Genome Research Institute (NHGRI) study section on Ethical, Legal and Social Issues (ELSI) and Human Genetics. He has been invited to participate in National Institutes of Health (NIH) planning workshops on the future of genomic medicine, and has been a featured or plenary speaker on translational genomics and personalized medicine at meetings of the World Science Festival, the National Coalition for Health Professional Education in Genetics, the American Academy of Neurology, the Consumer Genetics Conference, the World Congress of Psychiatric Genetics, the American Society of Human Genetics, the National Press Club and the Bio IT World Conference.
He is a Board Member of the Council for Responsible Genetics and was a plenary speaker on the topic of “Translational Genomics” at the Presidential Symposium of the 2011 American College of Medical Genetics and Genomics.